Copyright Reports & Markets. All rights reserved.

Global RNAi Technologies Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 RNAi Technologies Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global RNAi Technologies Market Size Growth Rate by Product
      • 1.4.2 Oncology
      • 1.4.3 Ocular disorders
      • 1.4.4 Respiratory disorders
      • 1.4.5 Liver diseases
      • 1.4.6 Other
    • 1.5 Market by End User
      • 1.5.1 Global RNAi Technologies Market Size Growth Rate by End User
      • 1.5.2 Research
      • 1.5.3 Therapeutics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global RNAi Technologies Market Size
      • 2.1.1 Global RNAi Technologies Revenue 2014-2025
      • 2.1.2 Global RNAi Technologies Sales 2014-2025
    • 2.2 RNAi Technologies Growth Rate by Regions
      • 2.2.1 Global RNAi Technologies Sales by Regions
      • 2.2.2 Global RNAi Technologies Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 RNAi Technologies Sales by Manufacturers
      • 3.1.1 RNAi Technologies Sales by Manufacturers
      • 3.1.2 RNAi Technologies Sales Market Share by Manufacturers
      • 3.1.3 Global RNAi Technologies Market Concentration Ratio (CR5 and HHI)
    • 3.2 RNAi Technologies Revenue by Manufacturers
      • 3.2.1 RNAi Technologies Revenue by Manufacturers (2014-2019)
      • 3.2.2 RNAi Technologies Revenue Share by Manufacturers (2014-2019)
    • 3.3 RNAi Technologies Price by Manufacturers
    • 3.4 RNAi Technologies Manufacturing Base Distribution, Product Types
      • 3.4.1 RNAi Technologies Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers RNAi Technologies Product Type
      • 3.4.3 Date of International Manufacturers Enter into RNAi Technologies Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global RNAi Technologies Sales by Product
    • 4.2 Global RNAi Technologies Revenue by Product
    • 4.3 RNAi Technologies Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global RNAi Technologies Breakdown Data by End User

    6 North America

    • 6.1 North America RNAi Technologies by Countries
      • 6.1.1 North America RNAi Technologies Sales by Countries
      • 6.1.2 North America RNAi Technologies Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America RNAi Technologies by Product
    • 6.3 North America RNAi Technologies by End User

    7 Europe

    • 7.1 Europe RNAi Technologies by Countries
      • 7.1.1 Europe RNAi Technologies Sales by Countries
      • 7.1.2 Europe RNAi Technologies Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe RNAi Technologies by Product
    • 7.3 Europe RNAi Technologies by End User

    8 Asia Pacific

    • 8.1 Asia Pacific RNAi Technologies by Countries
      • 8.1.1 Asia Pacific RNAi Technologies Sales by Countries
      • 8.1.2 Asia Pacific RNAi Technologies Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific RNAi Technologies by Product
    • 8.3 Asia Pacific RNAi Technologies by End User

    9 Central & South America

    • 9.1 Central & South America RNAi Technologies by Countries
      • 9.1.1 Central & South America RNAi Technologies Sales by Countries
      • 9.1.2 Central & South America RNAi Technologies Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America RNAi Technologies by Product
    • 9.3 Central & South America RNAi Technologies by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa RNAi Technologies by Countries
      • 10.1.1 Middle East and Africa RNAi Technologies Sales by Countries
      • 10.1.2 Middle East and Africa RNAi Technologies Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa RNAi Technologies by Product
    • 10.3 Middle East and Africa RNAi Technologies by End User

    11 Company Profiles

    • 11.1 Alnylam Pharmaceuticals
      • 11.1.1 Alnylam Pharmaceuticals Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Alnylam Pharmaceuticals RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Alnylam Pharmaceuticals RNAi Technologies Products Offered
      • 11.1.5 Alnylam Pharmaceuticals Recent Development
    • 11.2 Benitec Biopharma Ltd
      • 11.2.1 Benitec Biopharma Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Benitec Biopharma Ltd RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Benitec Biopharma Ltd RNAi Technologies Products Offered
      • 11.2.5 Benitec Biopharma Ltd Recent Development
    • 11.3 Filmtec Corporation
      • 11.3.1 Filmtec Corporation Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Filmtec Corporation RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Filmtec Corporation RNAi Technologies Products Offered
      • 11.3.5 Filmtec Corporation Recent Development
    • 11.4 Ionis Pharmaceuticals
      • 11.4.1 Ionis Pharmaceuticals Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Ionis Pharmaceuticals RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Ionis Pharmaceuticals RNAi Technologies Products Offered
      • 11.4.5 Ionis Pharmaceuticals Recent Development
    • 11.5 Quark Pharmaceuticals Inc.
      • 11.5.1 Quark Pharmaceuticals Inc. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Quark Pharmaceuticals Inc. RNAi Technologies Products Offered
      • 11.5.5 Quark Pharmaceuticals Inc. Recent Development
    • 11.6 RXI Pharmaceuticals
      • 11.6.1 RXI Pharmaceuticals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 RXI Pharmaceuticals RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 RXI Pharmaceuticals RNAi Technologies Products Offered
      • 11.6.5 RXI Pharmaceuticals Recent Development
    • 11.7 Qiagen
      • 11.7.1 Qiagen Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Qiagen RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Qiagen RNAi Technologies Products Offered
      • 11.7.5 Qiagen Recent Development
    • 11.8 Invitrogen
      • 11.8.1 Invitrogen Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Invitrogen RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Invitrogen RNAi Technologies Products Offered
      • 11.8.5 Invitrogen Recent Development
    • 11.9 Ambion
      • 11.9.1 Ambion Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Ambion RNAi Technologies Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Ambion RNAi Technologies Products Offered
      • 11.9.5 Ambion Recent Development

    12 Future Forecast

    • 12.1 RNAi Technologies Market Forecast by Regions
      • 12.1.1 Global RNAi Technologies Sales Forecast by Regions 2019-2025
      • 12.1.2 Global RNAi Technologies Revenue Forecast by Regions 2019-2025
    • 12.2 RNAi Technologies Market Forecast by Product
      • 12.2.1 Global RNAi Technologies Sales Forecast by Product 2019-2025
      • 12.2.2 Global RNAi Technologies Revenue Forecast by Product 2019-2025
    • 12.3 RNAi Technologies Market Forecast by End User
    • 12.4 North America RNAi Technologies Forecast
    • 12.5 Europe RNAi Technologies Forecast
    • 12.6 Asia Pacific RNAi Technologies Forecast
    • 12.7 Central & South America RNAi Technologies Forecast
    • 12.8 Middle East and Africa RNAi Technologies Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 RNAi Technologies Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
      The global RNAi Technologies market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the RNAi Technologies market based on company, product type, end user and key regions.

      This report studies the global market size of RNAi Technologies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of RNAi Technologies in these regions.
      This research report categorizes the global RNAi Technologies market by top players/brands, region, type and end user. This report also studies the global RNAi Technologies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Alnylam Pharmaceuticals
      Benitec Biopharma Ltd
      Filmtec Corporation
      Ionis Pharmaceuticals
      Quark Pharmaceuticals Inc.
      RXI Pharmaceuticals
      Qiagen
      Invitrogen
      Ambion

      Market size by Product
      Oncology
      Ocular disorders
      Respiratory disorders
      Liver diseases
      Other
      Market size by End User
      Research
      Therapeutics

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global RNAi Technologies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of RNAi Technologies market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global RNAi Technologies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of RNAi Technologies submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of RNAi Technologies are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of RNAi Technologies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now